Friday, 26 May 2017 - 5:30

Top stories

News of the week

Novartis in full restructuring mode: announces 250 more layoffs in US

Switzerland’s pharmaceutical giant Novartis announced it will cut 250 jobs in its US branches in the near future.  The company will consolidate its R&D data operations site in Hyderabad (India) by relocating there 11 statistical programmers from Cambridge (MA).   In…

Approvals

Procedures / New drug and device authorizations / Recommendations

Keytruda: first drug approved in US for biomarker-based cancers

FDA has approved for the first time a drug for the treatment of tumors based on a biomarker rather than the location in the body where they originated. The drug is MSD’s Keytruda (pembrolizumab), which was granted approval, by priority…

Companies

Healthcare market news

Novartis in full restructuring mode: announces 250 more layoffs in US

Switzerland’s pharmaceutical giant Novartis announced it will cut 250 jobs in its US branches in the near future.  The company will consolidate its R&D data operations site in Hyderabad (India) by relocating there 11 statistical programmers from Cambridge (MA).   In…

Chemistry

Market and Technology

Huntsman and Clariant merge and create nearly 14-billion-dollar group

Huntsman Corporation and Swiss-based Clariant today jointly announced a merger of equals through an all-stock transaction, creating a company named HuntsmanClariant, with sales of approximately $13.2bn, an EBITDA of $2.3bn and 32,000 employees. As part of the agreement, Clariant’s shareholders…

M&A

Mergers & Acquisitions

AstraZeneca sells Seloken (metoprolol) to Recordati for €270m

AstraZeneca announced it sold its rights to Seloken and Seloken ZOK (metoprolol tartrate) in Europe to Italy-based Recordati for €270m. Seloken and Seloken ZOK are beta‐blockers for the treatment of hypertension, angina pectoris and other cardiovascular diseases. They delivered sales…

Nutraceuticals

Food supplements

Vitamin D, sleep and chronic pain

A new review, just published on the Journal of Endocrinology, confirms the importance of vitamin D hormone as our health conditions controller. Its role as a modulator is believed to be linked both to a good sleep-wake pattern, and to…

Pathology

Latest developments

Ebola recrudescence in Africa: Merck & Co. ready to provide vaccine to authorities

World Health Organization (WHO) reported a recrudescence of Ebola in the Democratic Republic of the Congo, which already caused 3 deaths and 12 infected patients. Ebola rapidly spread in many African States in 2014, causing more than 11,000 deaths. The…

Safety

News on Product Safety

UCB loses 13% in capitalization over few hours due to investigational osteoporosis drug

UCB’s shares fell over 13% today (Brussels), as it was announced that FDA is likely to refuse to grant approval for investigational osteoporosis treatment romosozumab this year, contrary to a previous statement. Romosozumab was co-developed with US-based biotech company Amgen…

Trials

Preclinical Trials / Clinical Trials / Epidemiology

Pfizer launches major attack on cancer

Pfizer announced it submitted as many as 50 abstract to the organizing committee of the Annual Meeting of the American Society of Clinical Oncology (ASCO), to be held in Chicago from June 2 to 6. The announcement is aimed at…